Li J, Norwood DL, Mao LF, Schulz H: Mitochondrial metabolism of valproic acid
56 A phase 2b randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of pegblefermin in patients with NASH and stage 3 fibrosis is active but not recruiting any new patients
Wegovy is the exact same medication as Ozempic, but it's prescribed for weight loss, rather than diabetes
Glutathione production in cells declines naturally at an average rate of 10% per decade after age 20
Clinical trials have shown it can facilitate significant weight loss, with participants losing about 15% of their body weight over 68 weeks
For practical guidance on managing appetite changes, this article on appetite suppression timelines is worth reading